Is the US prepared to deal with another pandemic or widespread health crisis?
The short answer is: The United States is technically more advanced in its scientific tools than it was before COVID-19, but it remains critically unprepared from an infrastructure, funding, and policy standpoint.
While the U.S. has developed world-class biotechs, early warning detection systems, and rapid vaccine manufacturing pipelines, public health watchdogs, government accountability reports, and medical experts warn that the nation’s public health infrastructure has significantly backslid. A combination of deep funding cuts, staff burnout, political polarization, and legislative gridlock has left the country highly vulnerable to the next major health crisis.
The current state of U.S. pandemic preparedness is characterized by a mix of key advancements and deep systemic vulnerabilities.
1. Where the U.S. is Better Prepared (Technological & Scientific Strengths)
The medical and technological leaps achieved during and after the COVID-19 pandemic have vastly improved the country's scientific "toolkit."
2. Where the U.S. Has Backslid (Infrastructure & Workforce Gaps)
Despite technological progress, the underlying human and institutional architecture of American public health has eroded.
3. Policy and Funding Volatility
Long-term preparedness requires predictable, sustained funding, yet the U.S. remains trapped in a "panic-and-neglect" cycle.
4. The Litmus Test: The H5N1 Avian Influenza Outbreak
The ongoing management of the H5N1 avian flu outbreak (which has spread across wild birds, domestic poultry, and U.S. dairy herds) has served as a real-time test of whether the U.S. learned its lessons from COVID-19. The response has yielded mixed results:
Conclusion
If another highly virulent pathogen were to emerge, the U.S. would likely be able to develop and manufacture a vaccine faster than any other nation in history. However, the country would struggle immensely to distribute those therapeutics equitably, convince a skeptical public to accept them, find enough nurses and doctors to staff overwhelmed hospitals, and coordinate a unified state and federal response. Until the U.S. stabilizes public health funding, reauthorizes its core biodefense legislation, and repairs institutional trust, it remains highly vulnerable to the next widespread health crisis.
Citations (16)
- umn.edu
Backs: “While the U.S. has developed world-class biotechs, early warning detection systems, and rapid vaccine manufacturing pipelines, public health watchdogs, government accountability reports, and medical experts warn that the nation’s public health infrastructure has significantly backslid. A combination of deep funding…”
- pandorareport.org
Backs: “While the U.S. has developed world-class biotechs, early warning detection systems, and rapid vaccine manufacturing pipelines, public health watchdogs, government accountability reports, and medical experts warn that the nation’s public health infrastructure has significantly backslid. A combination of deep funding…”
- youtube.com
Backs: “While the U.S. has developed world-class biotechs, early warning detection systems, and rapid vaccine manufacturing pipelines, public health watchdogs, government accountability reports, and medical experts warn that the nation’s public health infrastructure has significantly backslid. A combination of deep funding…”
- tfah.org
Backs: “A combination of deep funding cuts, staff burnout, political polarization, and legislative gridlock has left the country highly vulnerable to the next major health crisis.”
- bstquarterly.com
Backs: “Where the U.S. is Better Prepared (Technological & Scientific Strengths). The medical and technological leaps achieved during and after the COVID-19 pandemic have vastly improved the country's scientific "toolkit.". Wastewater Surveillance: The CDC's National Wastewater Surveillance System (NWSS) has emerged as a…”
- asm.org
Backs: “Where the U.S. is Better Prepared (Technological & Scientific Strengths). The medical and technological leaps achieved during and after the COVID-19 pandemic have vastly improved the country's scientific "toolkit.". Wastewater Surveillance: The CDC's National Wastewater Surveillance System (NWSS) has emerged as a…”
- ghtcoalition.org
Backs: “Rapid Vaccine Platforms (mRNA): Because of sustained investment in mRNA and other platform technologies, the U.S. can design, test, and scale targeted medical countermeasures (like vaccines and therapeutics) within months rather than years. Improved Data Infrastructure: Before COVID-19, only a fraction of U.S.”
- gao.gov
Backs: “Crucially, the GAO warned of a lack of coordination between human health agencies (like the CDC) and animal health sectors (like the USDA). Since the vast majority of emerging pandemics originate in animals, this siloed approach is a critical blind spot.”
- gao.gov
Backs: “Crucially, the GAO warned of a lack of coordination between human health agencies (like the CDC) and animal health sectors (like the USDA). Since the vast majority of emerging pandemics originate in animals, this siloed approach is a critical blind spot.”
- csis.org
Backs: “Policy and Funding Volatility. Long-term preparedness requires predictable, sustained funding, yet the U.S. remains trapped in a "panic-and-neglect" cycle. PAHPA Has Lapsed: The Pandemic and All-Hazards Preparedness Act (PAHPA)—the fundamental law that funds and coordinates U.S.”
- astho.org
Backs: “PAHPA Has Lapsed: The Pandemic and All-Hazards Preparedness Act (PAHPA)—the fundamental law that funds and coordinates U.S. health emergency responses, the Strategic National Stockpile (SNS), and the Biomedical Advanced Research and Development Authority (BARDA)—initially expired in late 2023. Congress has kept these…”
- bio.news
Backs: “Without long-term reauthorization, the private biotechnology sector has less incentive to invest in decadelong R&D projects for emerging pathogens. State-Level Cuts: According to the Ready or Not report by Trust for America's Health, federal funding uncertainty has cascaded downward, prompting at least 12 states to…”
- premierinc.com
Backs: “Without long-term reauthorization, the private biotechnology sector has less incentive to invest in decadelong R&D projects for emerging pathogens. State-Level Cuts: According to the Ready or Not report by Trust for America's Health, federal funding uncertainty has cascaded downward, prompting at least 12 states to…”
- contagionlive.com
Backs: “The Litmus Test: The H5N1 Avian Influenza Outbreak. The ongoing management of the H5N1 avian flu outbreak (which has spread across wild birds, domestic poultry, and U.S. dairy herds) has served as a real-time test of whether the U.S. learned its lessons from COVID-19. The response has yielded mixed results:”
- nih.gov
Backs: “The Litmus Test: The H5N1 Avian Influenza Outbreak. The ongoing management of the H5N1 avian flu outbreak (which has spread across wild birds, domestic poultry, and U.S. dairy herds) has served as a real-time test of whether the U.S. learned its lessons from COVID-19. The response has yielded mixed results:”
- aspr.gov
Backs: “The Litmus Test: The H5N1 Avian Influenza Outbreak. The ongoing management of the H5N1 avian flu outbreak (which has spread across wild birds, domestic poultry, and U.S. dairy herds) has served as a real-time test of whether the U.S. learned its lessons from COVID-19. The response has yielded mixed results:”